COVID-19 vaccination and young children: What to know
Fox News
Elementary-aged children around the country are now eligible to receive a kid-sized shot of the Pfizer/BioNTech COVID-19 vaccine.
While Moderna and Johnson & Johnson vaccines are still being tested for children ages 5-11, last month the FDA affirmed results from Pfizer showing that its two-dose shot was nearly 91% effective at preventing symptomatic infection in young children.
While the Pfizer trial had some post-shot reactions, including sore arms and fatigue, 5- to 11-year-olds were less likely to have fevers and the FDA found no safety concerns.
More Related News
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.